BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10594354)

  • 21. A rapid and efficient in vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of cancer.
    Staquet K; Giles-Komar J
    Hybridoma (Larchmt); 2006 Apr; 25(2):68-74. PubMed ID: 16704306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Industrial implementation of in vitro production of monoclonal antibodies.
    Dewar V; Voet P; Denamur F; Smal J
    ILAR J; 2005; 46(3):307-13. PubMed ID: 15953838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dual-chamber system for screening cytotoxic effects of hybridoma-produced antibodies.
    Long TT; Kalantarov G; Chudner A; Trakht I
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):246-54. PubMed ID: 23909417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Production of monoclonal antibodies in serum-free medium in dialysis tubing].
    Witt S; Ziegler B; Blumentritt C; Schlosser M; Ziegler M
    Allerg Immunol (Leipz); 1991; 37(2):67-74. PubMed ID: 1801593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBs-MAb production in perfusion culture with selective ammonia removal system.
    Nayve FR; Misato T; Matsumura M; Kataoka H
    J Biotechnol; 1994 May; 34(3):217-25. PubMed ID: 7764955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of monoclonal antibody in hollow fiber culture system with serum-free medium.
    Zhou W; Cai S
    Chin J Biotechnol; 1992; 8(1):41-9. PubMed ID: 1457721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medium-scale production and purification of monoclonal antibodies in protein-free medium.
    Tarleton RL; Beyer AM
    Biotechniques; 1991 Nov; 11(5):590-3. PubMed ID: 1804247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free medium.
    Dhainaut F; Bihoreau N; Meterreau JL; Lirochon J; Vincentelli R; Mignot G
    Cytotechnology; 1992; 10(1):33-41. PubMed ID: 1369103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ion exchange resins for the purification of monoclonal antibodies from animal cell culture.
    Graf H; Rabaud JN; Egly JM
    Bioseparation; 1994 Feb; 4(1):7-20. PubMed ID: 7764588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of hollow-fiber bioreactor systems for large-scale production of murine monoclonal antibodies.
    Evans TL; Miller RA
    Targeted Diagn Ther; 1990; 3():25-43. PubMed ID: 2131012
    [No Abstract]   [Full Text] [Related]  

  • 31. Hybridoma antibody production in vitro in type II serum-free medium using Nutridoma-SP supplements. Comparisons with in vivo methods.
    Federspiel G; McCullough KC; Kihm U
    J Immunol Methods; 1991 Dec; 145(1-2):213-21. PubMed ID: 1765654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Getting higher yields of monoclonal antibody in culture.
    Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
    Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
    Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybridoma cells immobilized on nonwoven polyester fabric discs: proliferation and monoclonal antibody production in stationary culture.
    Aslankaraoğlu E; Gümüşderelioğlu M; Gürhan SI
    J Biomater Appl; 2003 Oct; 18(2):137-48. PubMed ID: 14621339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for increasing monoclonal antibody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content.
    Heath C; Dilwith R; Belfort G
    J Biotechnol; 1990 Jul; 15(1-2):71-89. PubMed ID: 1366689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lab-scale production of anti-Schistosoma monoclonal antibodies by hybridoma culturing in serum free medium: Enhancement of growth, cryopreservation survival rate, and diagnostic accuracy.
    Salah F; Maher K; Demerdash Z; El Baz H; Abdallah HH; Maher S; El Khateeb EM; Shawky SM
    Exp Parasitol; 2022 Nov; 242():108390. PubMed ID: 36179853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of murine monoclonal antibodies in serum-free medium.
    Liu RS; Ta D; Payne J; Coccia M; Kuus-Reichel K
    Hybridoma; 1998 Feb; 17(1):69-72. PubMed ID: 9523240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.